Cancer Research Sequencing Panels

Reduce cost per sample and analysis burden with highly focused targeted panels that enable deeper coverage of regions of interest.

Key Strengths

  • Sequences key genes or regions of interest to high depth using pre-designed, analytical validated panels
  • Provides cost-effective, actionable findings for cancer-relevant genes
  • Obtains highly accurate results with variants present down to 5% variant allele frequency

Panels Available

  • TruSight Cancer: contains 94 genes previously linked to a predisposition to cancer.
  • TruSight Tumor: targets 26 genes frequently mutated in solid tumors according to CAP and NCCN guidelines, and clinical trials.
  • TruSight Myeloid: targets 54 genes frequently mutated in myeloid malignancies.
  • TruSeq Amplicon-Cancer Panel: targets hotspot regions of frequently mutated genes in both solid and hematological cancers.